Delivery Order SPE2DB22D1202-SPE2DB24FULD8
- Not listed
- This federal contract award, valued at $3,407.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designations, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,162.70 firm fixed price delivery order is for the provision of Pfizer's COVID-19 vaccine over a term from June 2023 to March 2024. This contract is part of a larger DLA indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to...
- This contract award is for the delivery of Pfizer COVID-19 vaccines in support of the U.S. government's pandemic response efforts. The $2,162.70 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a completion date of February 22, 2024 and does not utilize any set-aside designations. Amerisourcebergen...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,162.70 firm fixed price delivery order is for the provision of Pfizer COVID-19 vaccines in 0.9 mL doses, with a period of performance from January 2023 through January 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies,...
- This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of Pfizer COVID-19 vaccines, with a period of performance from February 2025 to March 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, a $1,081.34 firm fixed price delivery order, is for the provision of Pfizer COVID-19 vaccine doses in the 6-month to 4-year dosage form under the Emergency Use Authorization (EUA). The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,135.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses in 0.9 mL vials. The contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses, with an ultimate completion date of December 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, worth $1,081.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with a period of performance from January 2023 to January 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses. The $1,081.35 award is for an estimated 0.9 ml doses to be delivered by January 4, 2024. Amerisourcebergen is a prime contractor that has previously supplied pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. This order is not associated with a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FULD8Delivery Order
This federal contract award is a $3,407.31 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Pfizer COVID-19 vaccines in 0.9 mL doses, with a period of performance from December 2023 through December 2024. The contract does not have a set-aside designation. As a prime contractor, Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical programs and facilities. This award is likely part of the U.S. government's ongoing efforts to procure COVID-19 vaccines and related medical supplies for military treatment and inoculation programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/27/23 |